Cargando…

JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells

BACKGROUND: Vascular smooth muscle cell (VSMC) phenotype switching is critical for neointima formation, which is the major cause of restenosis after stenting or coronary artery bypass grafting. However, the epigenetic mechanisms regulating phenotype switching of VSMCs, especially histone methylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yi, Yi, Xin, Zhang, Zihao, Luo, Hanshen, Li, Rui, Feng, Xin, Fang, Ze-Min, Zhu, Xue-Hai, Cheng, Wenlin, Jiang, Ding-Sheng, Zhao, Fang, Wei, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375951/ https://www.ncbi.nlm.nih.gov/pubmed/35964071 http://dx.doi.org/10.1186/s13148-022-01321-8

Ejemplares similares

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
por: Parrish, Janet K., et al.
Publicado: (2018)

Cooperation between ETS variant 2 and Jumonji domain-containing 2 histone demethylases
por: Li, Xiaomeng, et al.
Publicado: (2018)

Systematic discovery of genetic modulation by Jumonji histone demethylases in Drosophila
por: Shalaby, Nevine A., et al.
Publicado: (2017)

JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
por: Kim, Min Seong, et al.
Publicado: (2018)

JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells
por: Lee, Jina, et al.
Publicado: (2022)

Methyltransferase‐like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation
por: Fang, Ze‐Min, et al.
Publicado: (2022)

Jumonji C Demethylases in Cellular Senescence
por: Leon, Kelly E., et al.
Publicado: (2019)

Molecular architecture of the Jumonji C family histone demethylase KDM5B
por: Dorosz, Jerzy, et al.
Publicado: (2019)

Involvement of a Jumonji-C domain-containing histone demethylase in DRM2-mediated maintenance of DNA methylation
por: Deleris, Angelique, et al.
Publicado: (2010)

Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor
por: Singh, Balraj, et al.
Publicado: (2022)

Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase
por: Sinha, Krishna M, et al.
Publicado: (2010)

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
por: Wang, Lei, et al.
Publicado: (2013)

Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
por: Koca, Duygu, et al.
Publicado: (2020)

Genome-wide identification of the jumonji C domain- containing histone demethylase gene family in wheat and their expression analysis under drought stress
por: Wang, Xinhua, et al.
Publicado: (2022)

JIB 2003: fidèlesàelles-mêmes
por: J.-M.M.
Publicado: (2003)

A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer
por: Li, Xiaomeng, et al.
Publicado: (2018)

Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3
por: Ning, Ke, et al.
Publicado: (2020)

Inhibition of Jumonji demethylases reprograms severe dilated cardiomyopathy and prolongs survival
por: Tran, Tram Anh, et al.
Publicado: (2021)

JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis
por: Son, Juhee, et al.
Publicado: (2021)

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
por: Son, Juhee, et al.
Publicado: (2022)

The Jumonji Domain-Containing Histone Demethylase Homolog 1D/lysine Demethylase 7A (JHDM1D/KDM7A) Is an Epigenetic Activator of RHOJ Transcription in Breast Cancer Cells
por: Zhang, Ziyu, et al.
Publicado: (2021)

Stage-Dependent and Locus-Specific Role of Histone Demethylase Jumonji D3 (JMJD3) in the Embryonic Stages of Lung Development
por: Li, Qingtian, et al.
Publicado: (2014)

Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
por: Ene, Chibawanye I., et al.
Publicado: (2012)

Corrigendum: The Jumonji Domain-Containing Histone Demethylase Homolog 1D/lysine Demethylase 7A (JHDM1D/KDM7A) Is an Epigenetic Activator of RHOJ Transcription in Breast Cancer Cells
por: Zhang, Ziyu, et al.
Publicado: (2021)

Cell-type-specific Jumonji histone demethylase gene expression in the healthy rat CNS: detection by a novel flow cytometry method
por: Smith, Stephanie M.C., et al.
Publicado: (2014)

Correction: Stage-Dependent and Locus-Specific Role of Histone Demethylase Jumonji D3 (JMJD3) in the Embryonic Stages of Lung Development
por: Li, Qingtian, et al.
Publicado: (2023)

Disruption of the Plasmodium falciparum Life Cycle through Transcriptional Reprogramming by Inhibitors of Jumonji Demethylases
por: Matthews, Krista A., et al.
Publicado: (2020)

Evaluation of Jumonji C lysine demethylase substrate preference to guide identification of in vitro substrates
por: Hoekstra, Matthew, et al.
Publicado: (2022)

Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG
por: Nikolaev, Anatoly, et al.
Publicado: (2020)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: FANG, LIPING, et al.
Publicado: (2016)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: Fang, Liping, et al.
Publicado: (2016)

Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3
por: Jung, Ji-Won, et al.
Publicado: (2010)

The roles of METTL3 on autophagy and proliferation of vascular smooth muscle cells are mediated by mTOR rather than by CDK1
por: Luo, Hanshen, et al.
Publicado: (2023)

Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15
por: Duan, Lei, et al.
Publicado: (2022)

The Memory of Environmental Chemical Exposure in C. elegans Is Dependent on the Jumonji Demethylases jmjd-2 and jmjd-3/utx-1
por: Camacho, Jessica, et al.
Publicado: (2018)

Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
por: Zheng, Heng, et al.
Publicado: (2019)

A Game to Deal With Alcohol Abuse (Jib): Development and Game Experience Evaluation
por: Carvalho, Darlinton Barbosa Feres, et al.
Publicado: (2019)

KdmB, a Jumonji Histone H3 Demethylase, Regulates Genome-Wide H3K4 Trimethylation and Is Required for Normal Induction of Secondary Metabolism in Aspergillus nidulans
por: Gacek-Matthews, Agnieszka, et al.
Publicado: (2016)

Jumonji domain‐containing protein 6 protein and its role in cancer
por: Yang, Jing, et al.
Publicado: (2020)

Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1α/HMOX1 axis
por: Shi, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0pna1fn7lme2icaiukb6vvfkdd